- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06318117
Reason for Prescribing Rice Infant Formula
Observational Study on the Use of Infant Formulas Based on Rice Protein Hydrolysate in Real Life Conditions
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Amy Benson, MS
- Phone Number: 8124298905
- Email: amy.benson@reckitt.com
Study Contact Backup
- Name: Jami Walker
- Phone Number: 8124297299
- Email: jami.walker@reckitt.com
Study Locations
-
-
-
Auxerre, France, 89011
- Centre Hospitalier d'Auxerre - Neonatology and pediatric emergency department
-
Contact:
- Bertrand Soto, MD
-
Nantes, France, 44093
- Centre Hospitalier Universitaire de Nantes - Pediatric emergency department
-
Contact:
- Hugues Piloquet, MD
-
Pontoise, France, 95300
- Hôpital NOVO - Pediatric department
-
Contact:
- Mariana Englender, MD
-
-
Becon-les-Granits
-
Bécon-les-Granits, Becon-les-Granits, France, 49026
- Dr Christine REGIMBART - Private Practice
-
Contact:
- Christine Regimbart, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Child aged between 6 and 11 months,
- Child who has already consumed a RIF for at least one month, or still consuming a RIF, or who will benefit from taking a RIF, according to the pediatrician,
- Legal representatives (parents/guardians) deemed capable of following the requirements of the protocol and have given their consent orally.
Exclusion Criteria:
- Child with a clinically relevant and significant abnormality in the medical history or on physical examination;
- Child who has been hospitalized in a neonatology unit (due to prematurity, malformation or neonatal pathology), or born with a low birth weight (≤ 2,500 g);
- For children not diversified at the time of starting RIF: mixed feeding with RIF and breast milk and/or infant formula based on cow's milk;
- Child born to minor parent(s);
- Infant or infant's family unable to comply with study protocol or procedures, in the judgment of the investigator;
- Participation in any other clinical trial prior to inclusion;
- Refusal of the Parents / legal representatives of the child, or who do not master the French language well enough to understand the information letter.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Rice infant formula started before age of 6 months
After inclusion (V1), infants will return for a V2 visit at 12 months (± 30 days) of age (according to the child's regular appointment calendar). No visit is imposed by the protocol. Anthropometric data from visits to the pediatrician carried out between V1 and V2 will be collected from medical records, as well as the date of cessation of RIF, if applicable. Retrospective data will be collected from medical files (anthropometric data, medical and feeding history) and from parents' and investigator's recall. |
Any commercially available rice infant formula whom the pediatrician has previously deemed, or is deeming it useful to consume.
|
Rice infant formula started after age of 6 months
After inclusion (V1), infants will return for a V2 visit at 12 months (± 30 days) of age (according to the child's regular appointment calendar). No visit is imposed by the protocol. Anthropometric data from visits to the pediatrician carried out between V1 and V2 will be collected from medical records, as well as the date of cessation of RIF, if applicable. Retrospective data will be collected from medical files (anthropometric data, medical and feeding history) and from parents' and investigator's recall. |
Any commercially available rice infant formula whom the pediatrician has previously deemed, or is deeming it useful to consume.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Questionnaire - reason for prescribing a RIF during the 1st year of life.
Time Frame: 1 to 7 months
|
The main objective is to describe the main reason for prescribing a RIF by the pediatrician during the 1st year of life.
|
1 to 7 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Questionnaire - Reason for prescribing a RIF in first 6 months of life
Time Frame: up to 365 days of age
|
o describe the main reason for prescribing a RIF by the pediatrician during the 1st 6 months of life.
|
up to 365 days of age
|
Questionnaire - Diet characteristics
Time Frame: up to 365 days of age
|
To describe the conditions of RIF consumption during the follow-up, and the other main characteristics of the diet.
|
up to 365 days of age
|
Growth z-scores body mass index (BMI)-for-age
Time Frame: up to 365 days of age
|
body mass index (BMI)-for-age
|
up to 365 days of age
|
Growth z-score
Time Frame: up to 365 days of age
|
Weight-for-age z-score
|
up to 365 days of age
|
Growth z-score
Time Frame: up to 365 days of age
|
Length/Height-for-age z-score
|
up to 365 days of age
|
Growth z-score
Time Frame: up to 365 days of age
|
Weight-for-length/height z-score
|
up to 365 days of age
|
Growth z-score
Time Frame: up to 365 days of age
|
Head circumference-for-age z-score
|
up to 365 days of age
|
Questionnaire - Evolution of digestive and allergic symptoms
Time Frame: up to 365 days of age
|
To describe the evolution of digestive and allergic symptoms during follow-up.
|
up to 365 days of age
|
Socio-demographic characteristics
Time Frame: up to 365 days of age
|
To describe the socio-demographic characteristics of the infants' families
|
up to 365 days of age
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Hugues Piloquet, MD, CHU Nantes Children's chronic disease service
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 3398-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant Formula
-
Xinhua Hospital, Shanghai Jiao Tong University...CompletedInfant Formula IntoleranceChina
-
Wageningen UniversityFrieslandCampinaCompleted
-
NestléCompletedInfant Formula | Infant Nutritional Physiological PhenomenaSaudi Arabia
-
NestléCompletedInfant Formula IntolerancePhilippines
-
National Institute of Environmental Health Sciences...CompletedInfant Formula | Estrogen ActivityUnited States
-
Sun Yat-sen UniversityCompleted
-
Sun Yat-sen UniversityUnknownWell-being | Infant Formula IntoleranceChina
-
Société des Produits Nestlé (SPN)RecruitingInfant Development | Growth and Development | Infant Health | Infant Formula | Infant Nutritional Physiological PhenomenaSaudi Arabia
-
Umeå UniversityUniversity of California; Mead Johnson NutritionActive, not recruitingHealth of Formula-fed Children | Infant Infections in Formula-fed Children | Iron Status of Formula-fed ChildrenSweden
Clinical Trials on Rice infant formula
-
Dr. Schär AG / SPACompleted
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Jovie USA, LLCIQVIA RDS Inc.; ObvioHealthCompleted
-
Société des Produits Nestlé (SPN)University College, LondonCompletedGrowth | Infant FormulaUnited Kingdom
-
Nara OrganicsPaidion Research, Inc.Completed
-
Abbott NutritionCompleted
-
Société des Produits Nestlé (SPN)Completed